Sydney Paden, PA
Physician Assistant · Gilbert, AZNPI 1689282287
Payments from drug & device makers
Across 190 payments — averaging $16.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$718
- Pfizer$299
- Lucid Diagnostics Inc.$267
- AstraZeneca$249
- Biohaven Pharmaceutical Holding Company Ltd.$245
- Lilly USA, LLC$227
- plus $1K from 25 others
What the payments were for
- Food & beverage$3,035100%
- Education$140%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 47 | $718 |
| Pfizer | 20 | $299 |
| Lucid Diagnostics Inc. | 9 | $267 |
| AstraZeneca | 16 | $249 |
| Biohaven Pharmaceutical Holding Company Ltd. | 18 | $245 |
| Lilly USA, LLC | 15 | $227 |
| Novo Nordisk | 10 | $140 |
| Biohaven Pharmaceuticals, Inc. | 9 | $114 |
| Boehringer Ingelheim | 5 | $95 |
| Abbott | 5 | $94 |
| Amgen(2 entities) | 5 | $77 |
| Dexcom, Inc. | 4 | $75 |
| Bausch Health US, LLC | 2 | $49 |
| Sanofi-aventis U.S. LLC | 3 | $47 |
| Dynavax Technologies Corporation | 2 | $42 |
| Impulse Dynamics (USA) Inc. | 2 | $40 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $39 |
| Merck | 2 | $25 |
| GSK | 1 | $22 |
| IBSA Pharma Inc. | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
| Eisai Inc. | 1 | $17 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
| Optinose US, Inc. | 1 | $16 |
| Bayer | 1 | $15 |
| Mycovia Pharmaceuticals, Inc. | 1 | $15 |
| Sanofi Pasteur Inc. | 1 | $15 |
| Kaleo, Inc. | 1 | $14 |
| Azurity Pharmaceuticals, Inc. | 1 | $14 |
| Cranial Technologies, Inc | 1 | $13 |
| Idorsia Pharmaceuticals US Inc | 1 | $12 |
How this compares
$3,049 in reported general payments places this provider in the 85th percentile of 2,888 physician assistant providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 50 | $430 |
| Atorvastatin Calcium | 34 | $406 |
| Losartan Potassium | 37 | $400 |
| Tamsulosin Hcl | 15 | $362 |
| Amlodipine Besylate | 32 | $288 |
| Pantoprazole Sodium | 13 | $241 |
| Rosuvastatin Calcium | 27 | $239 |
| Omeprazole | 18 | $209 |
| Lisinopril | 27 | $144 |
| Metformin Hcl | 15 | $84 |
| Citalopram HbrCitalopram Hydrobromide | 11 | $62 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Gilbert
- Jenna HiltonGilbert$637K
- Brian BrinegarGilbert$33K
- Amanda EdmondGilbert$32K
- Jesse LyonGilbert$28K
- Sylvia PhommalinhGilbert$27K
- Kimberly JaredGilbert$22K
- Daniel PetersGilbert$18K
- Samuel FoxGilbert$15K
- Sabrina JamielGilbert$13K
- Jacob WhitneyGilbert$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.